Glucocorticoids Improve Renal Responsiveness to Atrial Natriuretic Peptide by Up-Regulating Natriuretic Peptide Receptor-A Expression in the Renal Inner Medullary Collecting Duct in Decompensated Heart Failure

@article{Liu2011GlucocorticoidsIR,
  title={Glucocorticoids Improve Renal Responsiveness to Atrial Natriuretic Peptide by Up-Regulating Natriuretic Peptide Receptor-A Expression in the Renal Inner Medullary Collecting Duct in Decompensated Heart Failure},
  author={Chao Liu and Ying Chen and Yunxiao Kang and Z. Ni and Heming Xiu and Jing Guan and Kunshen Liu},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2011},
  volume={339},
  pages={203 - 209}
}
In heart failure, the renal responsiveness to exogenous and endogenous atrial natriuretic peptide (ANP) is blunted. The mechanisms of renal hyporesponsiveness to ANP are complex, but one potential mechanism is decreased expression of natriuretic peptide receptor-A (NPR-A) in inner medullary collecting duct (IMCD) cells. Newly emerging evidence shows that glucocorticoids could produce potent diuresis and natriuresis in patients with heart failure, but the precise mechanism is unclear. In the… 
View on Publisher
jpet.aspetjournals.org
35 Citations
Highly Influential Citations
1
Background Citations
15
Methods Citations
1
Results Citations
1

Figures from this paper

35 Citations

Dexamethasone‐induced diuresis is associated with inhibition of the renin–angiotensin–aldosterone system in rats

Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats

TLDR
The pressure‐volume loop analysis showed that dexamethasone improves cardiac function in rats with heart failure and can reverse diluted hyponatremia via inhibiting the vasopressin receptor pathway in ratsWith heart failure.

Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

TLDR
The present results demonstrate that the treatment of the haplotype Npr1+/- mice with ATRA-NaBu significantly lowered blood pressure and reduced the renal inflammation and fibrosis involving the interactive roles of HDAC, NF-κB (p65), and STAT1.

Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes

TLDR
DEX modulates the production of cGMP in podocytes stimulated with vasoactive factors such as Ang II, ANP, and NO, and the effect is time-dependent, which may account for the antiproteinuric effect of glucocorticoids.

Altered vasopressin and natriuretic peptide levels in a rat model of spinal cord injury: implications for the development of polyuria.

TLDR
This study identifies several therapeutic targets that could be used to ameliorate polyuria symptoms and improve quality of life in individuals with SCI.

Effect of Corticosteroid on Renal Water and Sodium Excretion in Symptomatic Heart Failure: Prednisone for Renal Function Improvement Evaluation Study

TLDR
Only low-dose prednisone significantly enhanced urine output and renal sodium excretion, and high-dose Prednisone induced a more potent natriuresis and diuresis induced byprednisone.

Cardiac Outcome Prevention Effectiveness of Glucocorticoids in Acute Decompensated Heart Failure: COPE-ADHF Study

TLDR
Limited data indicate that glucocorticoid therapy may be used safely in patients with acute decompensated heart failure in short term, and there was a remarkable SCr reduction after 7 days treatment.

ZSF1 rat: a model of chronic cardiac and renal diseases in the context of metabolic syndrome. Characterization with anti-oxidant, mineralocorticoid receptor antagonist and aldosterone synthase inhibitor

TLDR
It was shown in this model that an aldosterone synthase inhibitor induced overall better renal protection than the mineralocorticoid receptor antagonist eplerenone, and showed that ZSF1-AngII rat is a suitable model to evaluate the cardio and renoprotective effects of drugs in the context of metabolic syndrome.

Inhibition of HDAC enhances STAT acetylation, blocks NF- (cid:2) B, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice

TLDR
The objective of the present study was to determine the physiological efficacy and impact of all- trans -retinoic acid (ATRA) and sodium butyrate (NaBu) in ameliorating the renal fibrosis, inflammation, and hypertension in Npr1 gene-disrupted haplotype male mice.

Histone Deacetylase Inhibitors Modulate the Transcriptional Regulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Gene

TLDR
The results suggest that epigenetic mechanisms regulate NPRA gene transcription, and define a novel epigenetic regulatory mechanism that governs Npr1 gene transcription.

References

SHOWING 1-10 OF 43 REFERENCES

Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.

TLDR
It is demonstrated that HS-142-1 markedly attenuates exogenous atrial natriuretic peptide-mediated natriuresis via enhancement of distal tubular reabsorption and blunting of increases in glomerular filtration rate.

Inhibition of Dehydration-Induced Water Intake by Glucocorticoids Is Associated with Activation of Hypothalamic Natriuretic Peptide Receptor-A in Rat

TLDR
It is found that dexamethasone pretreatment not only produced potent diuresis, but dramatically inhibited the dehydration-induced water intake, which indicated a possible physiologic role for glucocorticoids in the hypothalamic control of water intake and revealed that the glucocorts can act centrally as well as peripherally, to assist in the normalization of extracellular fluid volume.

Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.

TLDR
Reduced NPR-A protein levels, not receptor dephosphorylation, explain the renal hyporesponsiveness to natriuretic peptides in CHF.

Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro.

TLDR
Findings indicate that glucocorticoids stimulate expression of the ANP gene directly at the level of the myocardial cell, which results predominantly from transcriptional activation in cells already expressing the gene rather than through recruitment of previously quiescent cells.

Atrial Natriuretic Factor Effects on Cyclic Nucleotides in a Human Renal Cell Line

TLDR
This is the first report of an ANF responsive human renal cell line, and its use should facilitate investigation of ANFreceptor interactions.

Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.

TLDR
In severe chronic experimental CHF, glomerular cGMP accumulation decreases in response to both ANP and SNP, and CHF is characterized by enhanced cG MP- and cGmp-PDE activities that may participate in glomersular maladaptation to this cardiovascular syndrome.

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

TLDR
The authors investigated atrial natriuretic factor (ANF) in humans, measuring plasma immunoreactive (ir) ANF, and renal, hormonal, and hemodynamic responses to ANF infusion, in normal subjects (NL) and congestive heart failure patients (CHF).

Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli.

TLDR
It is concluded that high salt feeding in the rat results in reduced glomerular ANP receptor density relative to values in salt restricted rats, and the mesangial cell is a principal target for ANP binding in the glomerulus.

Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.

TLDR
Data show that HS ameliorates glomerular hyperfiltration in diabetic rats, further supporting the hypothesis that intrarenal actions of natriuretic peptides contribute significantly to glomersular hyperFiltration in experimental diabetes mellitus.

Mechanisms Involved in the Response to Prolonged Infusion of Atrial Natriuretic Factor in Patients With Chronic Heart Failure

TLDR
It is concluded that prolonged infusion of atrial natriuretic factor causes only transient increases in plasma cGMP levels but a sustained reduction of the cardiac release of ANF and that the beneficial hemodynamic effects of ANf may be associated with or, in part, may be secondary to a shift of plasma constituents into the extravascular space.